Bone and cartilage tissue engineering.

Standard

Bone and cartilage tissue engineering. / Boyan, B D; Lohmann, Christoph; Romero, J; Schwartz, Z.

In: CLIN PLAST SURG, Vol. 26, No. 4, 4, 1999, p. 629-645.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Boyan, BD, Lohmann, C, Romero, J & Schwartz, Z 1999, 'Bone and cartilage tissue engineering.', CLIN PLAST SURG, vol. 26, no. 4, 4, pp. 629-645. <http://www.ncbi.nlm.nih.gov/pubmed/10553218?dopt=Citation>

APA

Boyan, B. D., Lohmann, C., Romero, J., & Schwartz, Z. (1999). Bone and cartilage tissue engineering. CLIN PLAST SURG, 26(4), 629-645. [4]. http://www.ncbi.nlm.nih.gov/pubmed/10553218?dopt=Citation

Vancouver

Boyan BD, Lohmann C, Romero J, Schwartz Z. Bone and cartilage tissue engineering. CLIN PLAST SURG. 1999;26(4):629-645. 4.

Bibtex

@article{6fa25c3a63fa4946b4e20346b8f3e1e4,
title = "Bone and cartilage tissue engineering.",
abstract = "Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. This information base also has benefited cartilage tissue engineering. The problems are more complex, however, and the solutions appear more elusive. Advances in scaffold design and cell culture have improved the prognosis for success.",
author = "Boyan, {B D} and Christoph Lohmann and J Romero and Z Schwartz",
year = "1999",
language = "Deutsch",
volume = "26",
pages = "629--645",
journal = "CLIN PLAST SURG",
issn = "0094-1298",
publisher = "W.B. Saunders Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Bone and cartilage tissue engineering.

AU - Boyan, B D

AU - Lohmann, Christoph

AU - Romero, J

AU - Schwartz, Z

PY - 1999

Y1 - 1999

N2 - Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. This information base also has benefited cartilage tissue engineering. The problems are more complex, however, and the solutions appear more elusive. Advances in scaffold design and cell culture have improved the prognosis for success.

AB - Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. This information base also has benefited cartilage tissue engineering. The problems are more complex, however, and the solutions appear more elusive. Advances in scaffold design and cell culture have improved the prognosis for success.

M3 - SCORING: Zeitschriftenaufsatz

VL - 26

SP - 629

EP - 645

JO - CLIN PLAST SURG

JF - CLIN PLAST SURG

SN - 0094-1298

IS - 4

M1 - 4

ER -